The rarity of familial adenomatous polyposis (FAP) 
The rarity of familial adenomatous polyposis (FAP) means that many clinicians may be unaware of the major advances that have taken place in screening for the condition over the past five years. This review is not only to document the current scene but also to give details of those involved in establishing registries throughout the United Kingdom. FAP is a rare hereditary disease characterised by the development of large numbers of adenomatous polyps (more than 100) in the colon and rectum, which in the absence of surgical intervention invariably progress to adenocarcinoma. Until recently, identification of patients with FAP before they presented with clinical symptoms was largely dependent on sigmoidoscopic examination. Advances in the knowledge of the genetic defect' together with an appreciation of the predictive value of the extracolonic manifestations' have allowed identification of probable gene carriers. Accurate and helpful genetic counselling may thus be offered in the childbearing years. Written against the background of these recent developments, this review provides simple guidelines for clinicians involved in the management of such families.
For most doctors the general area of colonic polyps has become confused. The main distinctions which have helped our understanding have been based on histopathology, while the description of eponymous syndromes has confused rather than clarified the issues. An important historical landmark in our understanding of colonic polyps came from Woodward's distinction between neoplastic and inflammatory lesions in 18816 which was followed a year later by an account of a brother and sister who both had multiple adenomatous polyps in the rectum.7 As more elaborate pedigrees appeared the genetic nature of FAP was recognised8 and screening of relatives at risk by sigmoidoscopic examination followed shortly.9 The inheritance pattern of FAP was established as mendelian dominant without sex linkage.
The risk of malignancy in FAP was first noticed in 1887,10 but it was not until 1925 that Lockhart-Mummery postulated the adenomacarcinoma sequence." By the 1940s surgical removal of the colon was a sufficiently safe procedure to offer prophylaxis against the risk of colonic carcinoma in FAP patients. For the next 40 years colectomy remained a generally accepted procedure, but the last 10 years have seen two major developments -more effective screening for the disease and the increasing acceptance of panproctocolectomy with construction of an ileal reservoir.
Gardner's syndrome'2 is probably the best recognised eponymous condition linking colonic polyps with extracolonic manifestations of multiple epidermoid cysts, osteomas, and desmoid tumours. Similar expression of these features in FAP has led to the suggestion that the two syndromes are identical. Gene mapping of both conditions to chromosome 5q supports this view. The association of tumours of the central nervous system with FAP (Turcot's syndrome'3) and an association with endocrine neoplasia'4 are also probably different expressions of the same genetic defect.
Screening programme for FAP Some degree of scepticism has been expressed about the value of screening programmes, which in some instances identify the affected relatives with little opportunity to treat the detected disease. This is in striking contrast to FAP in which the risk of large bowel malignancy in affected relatives approaches 100%. The traditional practice of contacting several first degree relatives to carry out sigmoidoscopy may fail to identify many potential carriers in an extended family tree (Fig 1) . This immediately raises the question of who should conduct the search for other affected relatives, and a team approach involving the surgeon, a geneticist, and usually a genetic nurse is essential. that the presence of four or more lesions gives a sensitivity of 87-8% and a specificity of 100% in 48 unrelated 
Complications of surgery
In the Northern Region of England there have been no perioperative deaths but some postoperative morbidity occurred in 18 of 56 patients (32%). Overall there were 24 complications in 11 of the 22 panproctocolectomy patients, a rate of 50%. Ten patients needed their ileostomy refashioned, six needed a second laparotomy for small bowel obstruction and four had chronic problems with perineal infection and sinuses. While panproctocolectomy seems to be an attractive option since a single operation eradicates any risk of further rectal or colonic adenomas, there is increasing awareness that FAP is not purely a colonic disease4748 The disadvantages of a perineal wound, abdominal stoma, potential bladder and sexual dysfunction are disincentives to the use of panproctocolectomy as prophylaxis in FAP. It is still frequently used in patients who present with rectal carcinoma and require excision of the rectum as an essential part of their polyposis surgery. In contrast just three complications occurred in three IRA patients (rate 15%) and five complications in three pouch patients (rate 37 5%). The lower complication rate experienced after colectomy and IRA must be balanced against a 30% chance of requiring rectal excision within 10 years.
Polyposis registries (Table) Coordination of an effective regional screening programme is greatly facilitated by establishing a registry for FAP. The aims of a registry are to document all cases of FAP, establish the incidence and prevalence of the disease, and act as a forum for evaluation and discussion of new developments in screening and treatment of patients.
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